 "Wall St inches higher after five-day run, jobless data")
"Economic data has been consistently positive," said Peter Kenny, chief market strategist at Clearpool Group in New York. "We are positioned well into the close of the year and we have all sorts of validation that the economy, the corporate earnings story and markets are on the most solid footing they have been on in quite some time."
The Dow closed above 18,000 for the first time ever on Tuesday and the S&P 500 ended at its 51st record of the year after an unexpectedly strong report on US economic growth. The 51 new closing highs are the most since 1995 and fourth best in history. Equity markets will operate on a shortened trading schedule Wednesday, closing at 1 pm EST (1800 GMT) ahead of the Christmas Day holiday on Thursday. Volume is expected to be light, which could exacerbate volatility.
The benchmark S&P index has risen 5.5 per cent in its latest rally, the best five-day run since December 2011, fueled by a commitment by the US Federal Reserve last week to take a "patient" approach toward raising interest rates amid solid economic data.
S&P 500 e-mini futures were up two points and fair value, a formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract, indicated a slightly higher open. Dow Jones industrial average e-mini futures rose 33 points, and Nasdaq 100 e-mini futures added 4.75 points.
Adamas Pharmaceuticals Inc jumped 22.8 per cent to $17.99 before the opening bell after the US Food and Drug Administration approved a drug developed with Actavis Plc to treat dementia in Alzheimer's patients.
US surgical implant maker Stryker Corp is planning to make an offer for British medical device maker Smith & Nephew Plc that may come within weeks, Bloomberg reported, citing sources. US-listed shares of Smith & Nephew were down 1.4 per cent to $37.50 pre-market.